Bifeprunox in the Treatment of Schizophrenia
This study has been completed.
Information provided by:
First received: September 11, 2005
Last updated: March 20, 2008
Last verified: March 2008
Study of the long-term efficacy and safety of bifeprunox in the treatment of schizophrenia. Extension to study S154.3.001.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||An Open-Label, Flexible-Dose, Long-Term Safety and Efficacy Study of Bifeprunox in the Treatment of Schizpohrenia (Extension of S154.3.001)|
Resource links provided by NLM:
Further study details as provided by Solvay Pharmaceuticals:
Contacts and Locations